Pailin Bio (000403.SZ) released its first three quarters results, with net profit attributable to shareholders of RMB 150 million, down 57.92% year on year.

Zhitong Finance APP News, Pacific Shuanglin Bio-pharmacy (000403.SZ) released its 2026 third-quarter report. In the first three quarters, the company achieved operating revenue of 1.403 billion yuan, a year-on-year decrease of 13.29%; net profit attributable to shareholders of the listed company was 150 million yuan, a year-on-year decrease of 57.92%; net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 121 million yuan, a year-on-year decrease of 62.52%; basic earnings per share were 0.16 yuan.